Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
What is the latest us regulatory outcome for the drug anascorp?Nilotinib tasigna supplier?Furosemide expiry date?Vyvanse trends since fda approval?Clobazam production cost?
See the DrugPatentWatch profile for Edarbyclor
Edarbyclor is a prescription blood-pressure medicine that combines two drugs in one tablet: azilsartan medoxomil (40 mg) and chlorthalidone (12.5 mg). It is used to treat high blood pressure (hypertension).
The “40 12 5” format corresponds to the tablet’s strengths: - 40 mg of azilsartan medoxomil - 12.5 mg of chlorthalidone
Edarbyclor is typically prescribed when blood pressure is not controlled enough with azilsartan medoxomil or chlorthalidone alone, or when a clinician wants a combination approach to lower blood pressure further.
Because Edarbyclor includes a diuretic (chlorthalidone) and a blood-pressure medicine (azilsartan), patients and clinicians commonly monitor for blood-pressure lowering effects and electrolyte or kidney-related issues that can occur with thiazide-like diuretics (such as chlorthalidone). If you share the country you’re in and whether you mean “Edarbyclor 40/12.5” as a prescription, a price question, or patent/availability research, I can tailor the answer to that exact intent.
No sources provided in your prompt.
Other Questions About Edarbyclor :